Crossref
XANTUS-EL: A Real-World, Prospective, Observational Study of Patients Treated With Rivaroxaban For Stroke Prevention In Atrial Fibrillation In Eastern Europe, Middle East, Africa And Latin America
Cardiovascular Research Prove Journal · 2017
DOI: 10.21608/cvrepj.2017.352431 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research Prove Journal, 2017.
Themen: Schlaganfall
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2017). XANTUS-EL: A Real-World, Prospective, Observational Study of Patients Treated With Rivaroxaban For Stroke Prevention In Atrial Fibrillation In Eastern Europe, Middle East, Africa And Latin America. Cardiovascular Research Prove Journal. https://doi.org/10.21608/cvrepj.2017.352431
Vancouver
XANTUS-EL: A Real-World, Prospective, Observational Study of Patients Treated With Rivaroxaban For Stroke Prevention In Atrial Fibrillation In Eastern Europe, Middle East, Africa And Latin America. Cardiovascular Research Prove Journal. 2017. doi:10.21608/cvrepj.2017.352431
BibTeX
@article{euvimed2017,
title = {XANTUS-EL: A Real-World, Prospective, Observational Study of Patients Treated With Rivaroxaban For Stroke Prevention In Atrial Fibrillation In Eastern Europe, Middle East, Africa And Latin America},
journal = {Cardiovascular Research Prove Journal},
year = {2017},
doi = {10.21608/cvrepj.2017.352431}
}
EUVIMED